Company Profile

VitaThreads LLC
Profile last edited on: 6/27/2019      CAGE: 6SGU7      UEI: WP5NYWZN44P7

Business Identifier: Fibrin-based microthread technology
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

60 Prescott Street
Worcester, MA 01605
   (508) 762-1520
Location: Single
Congr. District: 02
County: Worcester

Public Profile

VitaThreads, LLC has developed a proprietary fibrin microthread technology intended for wound healing process in the aesthetic, reconstructive, and cosmetic surgery markets. A spinoff from Worcester Polytechnic Institute the firm is organized around commercializing that biopolymer microthread technology designed to produce new methods of stem cell delivery and new treatments for sports injuries and heart attacks, Building on the research of its founders at WPI's Bioengineering Institute, the firm is primarily addressing improved wound healing - using their product to enable clinicians to close wounds without scarring. The firm's flagship product - designated VitaSutures - is an advanced suture-like medical device meant to enhance repair of low-tension incisional wounds with minimal likelihood of scarring. Initially targeting the aesthetics market, where high-visibility procedures require a scarless closure solution, VitaSuture offers clinicians seeking an ideal aesthetic result to close skin incisions; and allows the body to return to a natural state without the prolonged presence of suture material and the complications associated with long suture persistence

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 1 NIH $179,011
Project Title: Fibrin Sutures for Non-Scarring Wound Closure
2013 1 NSF $149,477
Project Title: Improving cell loading efficiency for suture mediated cell therapy

Key People / Management

  Adam Collette -- President and CEO

  Harry Wonton -- Board member

  Bill Edelman -- Board Chairman

  Glenn Gaudette -- CTO

  George Pins -- CSO